REG - Maven Inc &Grwth VCT - Result of AGM

Maven Income and Growth VCTAnnouncement

06/07/2023 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230706:nRSF2305Fa&default-theme=true

RNS Number : 2305F  Maven Income & Growth VCT PLC  06 July 2023

 

Maven Income and Growth VCT PLC

 

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at Kintyre House, 205 West
George Street, Glasgow, G2 2LW at 12.00 noon on Thursday 6 July 2023, all of
the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 4 July 2023, the
total number of voting rights in the Company stood at 148,939,237 and the
total shares in issue were 148,939,237. The Company advises that, for the
Annual General Meeting, valid proxy appointments were made in respect of
7,094,849 shares and that the number of proxy votes lodged for each Resolution
were as follows:

 

     Resolutions                                                        For        Discretion  Against  Withheld  Total
 1   To receive the Directors' Report and audited Financial Statements  6,719,648  354,970     20,231   0         7,094,849
 2   To approve the Directors' Remuneration Report                      6,080,633  357,970     575,506  80,740    7,094,849
 3   To approve the Directors' Remuneration Policy                      5,942,540  357,970     704,353  89,986    7,094,849
 4   To approve the payment of a final dividend                         6,734,144  340,474     20,231   0         7,094,849

 5   To re-elect John Pocock as a Director                              6,555,402  375,334     129,708  34,405    7,094,849

 6   To re-elect Alison Fielding as a Director                          6,679,479  364,970     15,995   34,405    7,094,849

 7   To re-elect Andrew Harrington as a Director                        6,550,286  443,274     66,884   34,405    7,094,849

 8   To re-elect Arthur MacMillan as a Director                         6,518,558  376,289     165,597  34,405    7,094,849

 9   To appoint Johnston Carmichael LLP as Auditor                      6,694,155  373,289     0        27,405    7,094,849
 10  To authorise the Directors to fix the remuneration of the Auditor  6,593,675  426,957     53,815   20,402    7,094,849
 11  To renew the Company's authority to allot shares                   6,178,350  412,461     481,879  22,159    7,094,849
 12  To authorise the Directors to disapply pre-emption rights          6,029,455  427,461     615,774  22,159    7,094,849
 13  To renew the Company's authority to purchase its own shares        6,672,361  372,653     47,907   1,928     7,094,849
 14  To amend the minimum notice period for a general meeting           6,403,354  383,289     306,654  1,552     7,094,849

 

A vote withheld is not a vote in law and any such votes have not been included
in the votes for or against the respective Resolutions. The voting figures
will be available to view at: mavencp.com/migvct
(http://www.mavencp.com/migvct) .

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the
National Storage Mechanism and will shortly be available for inspection at:
fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
(https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism)

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

6 July 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSSFFEMEDSESW